Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on December 11, 2014. The filing reports a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the election of a director and does not contain financial performance data.
Material Changes
The Board of Directors increased its size from nine members to ten members. Michael J. Farrell was elected to fill the resulting vacancy, with a term expiring at the 2015 annual meeting of stockholders. Mr. Farrell was also appointed to the Compensation and Management Development Committee and the Research, Innovation and Technology Committee.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies were disclosed in this report. Mr. Farrell will participate in standard non-employee director compensation arrangements and is expected to execute a standard indemnification agreement.
Investor Verification Checklist
- Verify the biographical background and qualifications of the newly elected director, Michael J. Farrell.
- Review the definitive proxy statement filed on March 24, 2014, for details on non-employee director compensation.
- Confirm the terms of the standard non-employee director indemnification agreement referenced in the filing.
- Check for any subsequent filings regarding the 2015 annual meeting of stockholders.